Takara Bio (TSE:4974) Cash Flow for Dividends : 円-5,052 Mil (TTM As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Cash Flow for Dividends?

Takara Bio's cash flow for dividends for the three months ended in Mar. 2024 was 円-4 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was 円-5,052 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Takara Bio's quarterly payment of dividends declined from Sep. 2023 (円-175 Mil) to Dec. 2023 (円-1 Mil) but then increased from Dec. 2023 (円-1 Mil) to Mar. 2024 (円-4 Mil).

Takara Bio's annual payment of dividends increased from Mar. 2022 (円-1,923 Mil) to Mar. 2023 (円-3,968 Mil) and increased from Mar. 2023 (円-3,968 Mil) to Mar. 2024 (円-5,052 Mil).

Takara Bio Cash Flow for Dividends Historical Data

The historical data trend for Takara Bio's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Cash Flow for Dividends Chart

Takara Bio Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash Flow for Dividends

Get a 7-Day Free Trial

-841.00

-962.00

-1,923.00

-3,968.00

-5,052.00

Takara Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Dividends	Get a 7-Day Free Trial															-1.00	-4,872.00	-175.00	-1.00	-4.00

Takara Bio Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-5,052 Mil.

Takara Bio Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Takara Bio's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Takara Bio (TSE:4974) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

TF2:Germany

Address

Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058

Website

http://www.takara-bio.co.jp

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines